nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—SLC10A1—Progesterone—uterine cancer	0.103	0.16	CbGbCtD
Cyclosporine—ABCB11—Progesterone—uterine cancer	0.0494	0.077	CbGbCtD
Cyclosporine—ABCC10—Etoposide—uterine cancer	0.0407	0.0634	CbGbCtD
Cyclosporine—ABCC1—Progesterone—uterine cancer	0.0351	0.0547	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—uterine cancer	0.0278	0.0434	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—uterine cancer	0.0277	0.0432	CbGbCtD
Cyclosporine—ABCC3—Etoposide—uterine cancer	0.0256	0.0399	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—uterine cancer	0.0201	0.0314	CbGbCtD
Cyclosporine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0189	0.0294	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—uterine cancer	0.0186	0.029	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—uterine cancer	0.0174	0.0272	CbGbCtD
Cyclosporine—CYP3A7—Progesterone—uterine cancer	0.0173	0.027	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0173	0.027	CbGbCtD
Cyclosporine—ABCC1—Etoposide—uterine cancer	0.0157	0.0245	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—uterine cancer	0.0151	0.0235	CbGbCtD
Cyclosporine—ABCC2—Carboplatin—uterine cancer	0.0138	0.0216	CbGbCtD
Cyclosporine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0132	0.0205	CbGbCtD
Cyclosporine—CYP3A5—Progesterone—uterine cancer	0.013	0.0203	CbGbCtD
Cyclosporine—ABCG2—Carboplatin—uterine cancer	0.0125	0.0195	CbGbCtD
Cyclosporine—CYP2C8—Progesterone—uterine cancer	0.0125	0.0195	CbGbCtD
Cyclosporine—ABCC2—Etoposide—uterine cancer	0.0116	0.0181	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—uterine cancer	0.0107	0.0167	CbGbCtD
Cyclosporine—ABCG2—Etoposide—uterine cancer	0.0105	0.0164	CbGbCtD
Cyclosporine—CYP2C19—Progesterone—uterine cancer	0.0105	0.0164	CbGbCtD
Cyclosporine—CYP2C9—Progesterone—uterine cancer	0.00872	0.0136	CbGbCtD
Cyclosporine—ABCB1—Progesterone—uterine cancer	0.00846	0.0132	CbGbCtD
Cyclosporine—CYP2D6—Progesterone—uterine cancer	0.00798	0.0124	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—uterine cancer	0.00793	0.0124	CbGbCtD
Cyclosporine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00766	0.0119	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—uterine cancer	0.00717	0.0112	CbGbCtD
Cyclosporine—ABCB1—Dactinomycin—uterine cancer	0.00671	0.0105	CbGbCtD
Cyclosporine—CYP3A5—Etoposide—uterine cancer	0.00582	0.00907	CbGbCtD
Cyclosporine—CYP2C8—Etoposide—uterine cancer	0.0056	0.00872	CbGbCtD
Cyclosporine—FKBP4—oviduct—uterine cancer	0.00516	0.0508	CbGeAlD
Cyclosporine—CYP3A4—Progesterone—uterine cancer	0.00507	0.0079	CbGbCtD
Cyclosporine—ABCB1—Etoposide—uterine cancer	0.00379	0.0059	CbGbCtD
Cyclosporine—PPIB—oviduct—uterine cancer	0.0033	0.0325	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—uterine cancer	0.00258	0.00403	CbGbCtD
Cyclosporine—PPP3R2—female reproductive system—uterine cancer	0.00253	0.025	CbGeAlD
Cyclosporine—CYP2D6—Doxorubicin—uterine cancer	0.00243	0.00379	CbGbCtD
Cyclosporine—CYP3A4—Etoposide—uterine cancer	0.00227	0.00354	CbGbCtD
Cyclosporine—PPIB—exocrine gland—uterine cancer	0.0019	0.0187	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—uterine cancer	0.00155	0.00241	CbGbCtD
Cyclosporine—PPID—myometrium—uterine cancer	0.00152	0.015	CbGeAlD
Cyclosporine—CAMLG—myometrium—uterine cancer	0.0015	0.0148	CbGeAlD
Cyclosporine—PPIA—myometrium—uterine cancer	0.00137	0.0135	CbGeAlD
Cyclosporine—FKBP1B—female gonad—uterine cancer	0.00132	0.013	CbGeAlD
Cyclosporine—FKBP4—uterine cervix—uterine cancer	0.00128	0.0127	CbGeAlD
Cyclosporine—FKBP4—decidua—uterine cancer	0.00122	0.0121	CbGeAlD
Cyclosporine—SLC10A2—renal system—uterine cancer	0.00121	0.0119	CbGeAlD
Cyclosporine—FKBP4—renal system—uterine cancer	0.0012	0.0118	CbGeAlD
Cyclosporine—PPID—uterine cervix—uterine cancer	0.00119	0.0117	CbGeAlD
Cyclosporine—CAMLG—uterine cervix—uterine cancer	0.00117	0.0115	CbGeAlD
Cyclosporine—PPID—smooth muscle tissue—uterine cancer	0.00115	0.0113	CbGeAlD
Cyclosporine—PPID—decidua—uterine cancer	0.00113	0.0111	CbGeAlD
Cyclosporine—CAMLG—decidua—uterine cancer	0.00111	0.011	CbGeAlD
Cyclosporine—PPID—renal system—uterine cancer	0.00111	0.0109	CbGeAlD
Cyclosporine—PPIF—myometrium—uterine cancer	0.00111	0.0109	CbGeAlD
Cyclosporine—PPID—endometrium—uterine cancer	0.00107	0.0106	CbGeAlD
Cyclosporine—FKBP4—uterus—uterine cancer	0.00107	0.0105	CbGeAlD
Cyclosporine—PPP3CA—myometrium—uterine cancer	0.00106	0.0104	CbGeAlD
Cyclosporine—CAMLG—endometrium—uterine cancer	0.00106	0.0104	CbGeAlD
Cyclosporine—PPIB—myometrium—uterine cancer	0.00105	0.0104	CbGeAlD
Cyclosporine—PPID—mammalian vulva—uterine cancer	0.00104	0.0102	CbGeAlD
Cyclosporine—CAMLG—mammalian vulva—uterine cancer	0.00102	0.0101	CbGeAlD
Cyclosporine—CAMLG—uterus—uterine cancer	0.000974	0.00959	CbGeAlD
Cyclosporine—PPIA—endometrium—uterine cancer	0.000963	0.00948	CbGeAlD
Cyclosporine—FKBP4—female reproductive system—uterine cancer	0.000963	0.00948	CbGeAlD
Cyclosporine—PPIA—mammalian vulva—uterine cancer	0.000931	0.00917	CbGeAlD
Cyclosporine—PPID—female reproductive system—uterine cancer	0.000888	0.00875	CbGeAlD
Cyclosporine—PPIA—uterus—uterine cancer	0.000887	0.00874	CbGeAlD
Cyclosporine—SLC10A2—vagina—uterine cancer	0.000878	0.00865	CbGeAlD
Cyclosporine—FKBP4—female gonad—uterine cancer	0.000876	0.00863	CbGeAlD
Cyclosporine—CAMLG—female reproductive system—uterine cancer	0.000876	0.00862	CbGeAlD
Cyclosporine—PPIF—uterine cervix—uterine cancer	0.000862	0.00849	CbGeAlD
Cyclosporine—FKBP1B—lymph node—uterine cancer	0.000852	0.00839	CbGeAlD
Cyclosporine—PPIF—smooth muscle tissue—uterine cancer	0.000838	0.00825	CbGeAlD
Cyclosporine—PPIB—epithelium—uterine cancer	0.000828	0.00815	CbGeAlD
Cyclosporine—PPP3CA—uterine cervix—uterine cancer	0.000825	0.00813	CbGeAlD
Cyclosporine—PPIF—decidua—uterine cancer	0.000821	0.00809	CbGeAlD
Cyclosporine—PPIB—uterine cervix—uterine cancer	0.000821	0.00808	CbGeAlD
Cyclosporine—PPID—female gonad—uterine cancer	0.000808	0.00796	CbGeAlD
Cyclosporine—PPIF—renal system—uterine cancer	0.000807	0.00794	CbGeAlD
Cyclosporine—PPID—vagina—uterine cancer	0.000803	0.00791	CbGeAlD
Cyclosporine—PPP3CA—smooth muscle tissue—uterine cancer	0.000802	0.0079	CbGeAlD
Cyclosporine—PPIB—smooth muscle tissue—uterine cancer	0.000798	0.00785	CbGeAlD
Cyclosporine—CAMLG—female gonad—uterine cancer	0.000797	0.00785	CbGeAlD
Cyclosporine—CAMLG—vagina—uterine cancer	0.000792	0.0078	CbGeAlD
Cyclosporine—PPP3CA—decidua—uterine cancer	0.000786	0.00774	CbGeAlD
Cyclosporine—PPIB—decidua—uterine cancer	0.000782	0.0077	CbGeAlD
Cyclosporine—PPIF—endometrium—uterine cancer	0.00078	0.00768	CbGeAlD
Cyclosporine—PPP3CA—renal system—uterine cancer	0.000772	0.0076	CbGeAlD
Cyclosporine—PPIB—renal system—uterine cancer	0.000768	0.00756	CbGeAlD
Cyclosporine—PPIF—mammalian vulva—uterine cancer	0.000754	0.00743	CbGeAlD
Cyclosporine—PPP3CA—endometrium—uterine cancer	0.000747	0.00735	CbGeAlD
Cyclosporine—PPIB—endometrium—uterine cancer	0.000742	0.00731	CbGeAlD
Cyclosporine—PPIA—female gonad—uterine cancer	0.000726	0.00715	CbGeAlD
Cyclosporine—PPP3CA—mammalian vulva—uterine cancer	0.000722	0.00711	CbGeAlD
Cyclosporine—PPIA—vagina—uterine cancer	0.000721	0.0071	CbGeAlD
Cyclosporine—PPIF—uterus—uterine cancer	0.000719	0.00708	CbGeAlD
Cyclosporine—PPIB—mammalian vulva—uterine cancer	0.000718	0.00707	CbGeAlD
Cyclosporine—FKBP1A—myometrium—uterine cancer	0.000705	0.00694	CbGeAlD
Cyclosporine—PPP3CA—uterus—uterine cancer	0.000688	0.00677	CbGeAlD
Cyclosporine—PPIB—uterus—uterine cancer	0.000684	0.00674	CbGeAlD
Cyclosporine—SLC10A1—renal system—uterine cancer	0.000657	0.00647	CbGeAlD
Cyclosporine—PPIF—female reproductive system—uterine cancer	0.000646	0.00636	CbGeAlD
Cyclosporine—PPP3CA—female reproductive system—uterine cancer	0.000618	0.00609	CbGeAlD
Cyclosporine—PPIB—female reproductive system—uterine cancer	0.000615	0.00605	CbGeAlD
Cyclosporine—PPIF—female gonad—uterine cancer	0.000588	0.00579	CbGeAlD
Cyclosporine—PPIF—vagina—uterine cancer	0.000584	0.00575	CbGeAlD
Cyclosporine—ABCC10—myometrium—uterine cancer	0.000565	0.00556	CbGeAlD
Cyclosporine—FKBP4—lymph node—uterine cancer	0.000563	0.00555	CbGeAlD
Cyclosporine—PPP3CA—female gonad—uterine cancer	0.000563	0.00554	CbGeAlD
Cyclosporine—PPIB—female gonad—uterine cancer	0.000559	0.00551	CbGeAlD
Cyclosporine—PPP3CA—vagina—uterine cancer	0.000559	0.00551	CbGeAlD
Cyclosporine—PPIB—vagina—uterine cancer	0.000556	0.00548	CbGeAlD
Cyclosporine—FKBP1A—epithelium—uterine cancer	0.000553	0.00545	CbGeAlD
Cyclosporine—FKBP1A—uterine cervix—uterine cancer	0.000548	0.0054	CbGeAlD
Cyclosporine—FKBP1A—smooth muscle tissue—uterine cancer	0.000533	0.00525	CbGeAlD
Cyclosporine—SLC10A1—female reproductive system—uterine cancer	0.000526	0.00518	CbGeAlD
Cyclosporine—FKBP1A—decidua—uterine cancer	0.000523	0.00515	CbGeAlD
Cyclosporine—PPID—lymph node—uterine cancer	0.00052	0.00512	CbGeAlD
Cyclosporine—FKBP1A—renal system—uterine cancer	0.000513	0.00505	CbGeAlD
Cyclosporine—CAMLG—lymph node—uterine cancer	0.000512	0.00504	CbGeAlD
Cyclosporine—FKBP1A—endometrium—uterine cancer	0.000496	0.00488	CbGeAlD
Cyclosporine—FKBP1A—mammalian vulva—uterine cancer	0.00048	0.00472	CbGeAlD
Cyclosporine—PPIA—lymph node—uterine cancer	0.000467	0.00459	CbGeAlD
Cyclosporine—FKBP1A—uterus—uterine cancer	0.000457	0.0045	CbGeAlD
Cyclosporine—ABCC10—uterine cervix—uterine cancer	0.000439	0.00433	CbGeAlD
Cyclosporine—SLCO1B1—renal system—uterine cancer	0.000435	0.00429	CbGeAlD
Cyclosporine—ABCC3—decidua—uterine cancer	0.000421	0.00414	CbGeAlD
Cyclosporine—ABCC10—decidua—uterine cancer	0.000419	0.00412	CbGeAlD
Cyclosporine—ABCC3—renal system—uterine cancer	0.000413	0.00407	CbGeAlD
Cyclosporine—ABCC10—renal system—uterine cancer	0.000411	0.00405	CbGeAlD
Cyclosporine—FKBP1A—female reproductive system—uterine cancer	0.000411	0.00405	CbGeAlD
Cyclosporine—ABCC1—myometrium—uterine cancer	0.000399	0.00393	CbGeAlD
Cyclosporine—ABCC10—endometrium—uterine cancer	0.000397	0.00391	CbGeAlD
Cyclosporine—ABCC10—mammalian vulva—uterine cancer	0.000384	0.00379	CbGeAlD
Cyclosporine—PPIF—lymph node—uterine cancer	0.000378	0.00372	CbGeAlD
Cyclosporine—FKBP1A—female gonad—uterine cancer	0.000374	0.00368	CbGeAlD
Cyclosporine—FKBP1A—vagina—uterine cancer	0.000372	0.00366	CbGeAlD
Cyclosporine—ABCC10—uterus—uterine cancer	0.000366	0.00361	CbGeAlD
Cyclosporine—PPP3CA—lymph node—uterine cancer	0.000362	0.00356	CbGeAlD
Cyclosporine—PPIB—lymph node—uterine cancer	0.00036	0.00354	CbGeAlD
Cyclosporine—SLCO1A2—renal system—uterine cancer	0.000354	0.00349	CbGeAlD
Cyclosporine—SLCO1B1—female reproductive system—uterine cancer	0.000349	0.00343	CbGeAlD
Cyclosporine—ABCC3—female reproductive system—uterine cancer	0.000331	0.00326	CbGeAlD
Cyclosporine—ABCG2—myometrium—uterine cancer	0.000331	0.00326	CbGeAlD
Cyclosporine—ABCC2—renal system—uterine cancer	0.00033	0.00325	CbGeAlD
Cyclosporine—ABCC10—female reproductive system—uterine cancer	0.000329	0.00324	CbGeAlD
Cyclosporine—ABCC1—uterine cervix—uterine cancer	0.000311	0.00306	CbGeAlD
Cyclosporine—ABCC3—female gonad—uterine cancer	0.000301	0.00296	CbGeAlD
Cyclosporine—ABCC10—female gonad—uterine cancer	0.0003	0.00295	CbGeAlD
Cyclosporine—ABCC10—vagina—uterine cancer	0.000298	0.00293	CbGeAlD
Cyclosporine—ABCC1—decidua—uterine cancer	0.000296	0.00292	CbGeAlD
Cyclosporine—ABCC1—endometrium—uterine cancer	0.000281	0.00277	CbGeAlD
Cyclosporine—ABCC1—mammalian vulva—uterine cancer	0.000272	0.00268	CbGeAlD
Cyclosporine—ABCC2—female reproductive system—uterine cancer	0.000264	0.0026	CbGeAlD
Cyclosporine—ABCC1—uterus—uterine cancer	0.000259	0.00255	CbGeAlD
Cyclosporine—ABCG2—uterine cervix—uterine cancer	0.000257	0.00253	CbGeAlD
Cyclosporine—CYP2C8—renal system—uterine cancer	0.000248	0.00244	CbGeAlD
Cyclosporine—ABCG2—decidua—uterine cancer	0.000245	0.00241	CbGeAlD
Cyclosporine—FKBP1A—lymph node—uterine cancer	0.00024	0.00237	CbGeAlD
Cyclosporine—CYP2C8—endometrium—uterine cancer	0.000239	0.00236	CbGeAlD
Cyclosporine—CYP3A5—uterine cervix—uterine cancer	0.000239	0.00235	CbGeAlD
Cyclosporine—ABCG2—endometrium—uterine cancer	0.000233	0.00229	CbGeAlD
Cyclosporine—ABCG2—mammalian vulva—uterine cancer	0.000225	0.00222	CbGeAlD
Cyclosporine—CYP3A5—renal system—uterine cancer	0.000223	0.0022	CbGeAlD
Cyclosporine—ABCG2—uterus—uterine cancer	0.000214	0.00211	CbGeAlD
Cyclosporine—ABCC1—female gonad—uterine cancer	0.000212	0.00209	CbGeAlD
Cyclosporine—ABCC1—vagina—uterine cancer	0.000211	0.00207	CbGeAlD
Cyclosporine—CYP2C19—vagina—uterine cancer	0.000205	0.00202	CbGeAlD
Cyclosporine—CYP2C8—female reproductive system—uterine cancer	0.000198	0.00195	CbGeAlD
Cyclosporine—ABCC3—lymph node—uterine cancer	0.000194	0.00191	CbGeAlD
Cyclosporine—ABCC10—lymph node—uterine cancer	0.000193	0.0019	CbGeAlD
Cyclosporine—CYP2C8—vagina—uterine cancer	0.000179	0.00177	CbGeAlD
Cyclosporine—CYP2C9—female reproductive system—uterine cancer	0.000176	0.00173	CbGeAlD
Cyclosporine—ABCG2—female gonad—uterine cancer	0.000175	0.00173	CbGeAlD
Cyclosporine—ABCG2—vagina—uterine cancer	0.000174	0.00172	CbGeAlD
Cyclosporine—CYP3A4—renal system—uterine cancer	0.000168	0.00165	CbGeAlD
Cyclosporine—CYP2D6—renal system—uterine cancer	0.000165	0.00162	CbGeAlD
Cyclosporine—ABCB1—myometrium—uterine cancer	0.000163	0.00161	CbGeAlD
Cyclosporine—CYP3A5—female gonad—uterine cancer	0.000163	0.0016	CbGeAlD
Cyclosporine—CYP3A5—vagina—uterine cancer	0.000162	0.00159	CbGeAlD
Cyclosporine—ABCC2—lymph node—uterine cancer	0.000155	0.00152	CbGeAlD
Cyclosporine—ABCC1—lymph node—uterine cancer	0.000136	0.00134	CbGeAlD
Cyclosporine—CYP3A4—female reproductive system—uterine cancer	0.000134	0.00132	CbGeAlD
Cyclosporine—CYP2D6—female reproductive system—uterine cancer	0.000132	0.0013	CbGeAlD
Cyclosporine—ABCB1—epithelium—uterine cancer	0.000128	0.00126	CbGeAlD
Cyclosporine—ABCB1—uterine cervix—uterine cancer	0.000127	0.00125	CbGeAlD
Cyclosporine—ABCB1—decidua—uterine cancer	0.000121	0.00119	CbGeAlD
Cyclosporine—CYP2D6—female gonad—uterine cancer	0.00012	0.00118	CbGeAlD
Cyclosporine—ABCB1—renal system—uterine cancer	0.000119	0.00117	CbGeAlD
Cyclosporine—ABCB1—endometrium—uterine cancer	0.000115	0.00113	CbGeAlD
Cyclosporine—ABCG2—lymph node—uterine cancer	0.000113	0.00111	CbGeAlD
Cyclosporine—ABCB1—mammalian vulva—uterine cancer	0.000111	0.00109	CbGeAlD
Cyclosporine—ABCB1—uterus—uterine cancer	0.000106	0.00104	CbGeAlD
Cyclosporine—ABCB1—female reproductive system—uterine cancer	9.5e-05	0.000936	CbGeAlD
Cyclosporine—ABCB1—female gonad—uterine cancer	8.65e-05	0.000852	CbGeAlD
Cyclosporine—ABCB1—vagina—uterine cancer	8.6e-05	0.000847	CbGeAlD
Cyclosporine—Chest pain—Etoposide—uterine cancer	8.41e-05	0.000494	CcSEcCtD
Cyclosporine—Abdominal pain upper—Epirubicin—uterine cancer	8.39e-05	0.000493	CcSEcCtD
Cyclosporine—Affect lability—Doxorubicin—uterine cancer	8.37e-05	0.000492	CcSEcCtD
Cyclosporine—Migraine—Doxorubicin—uterine cancer	8.37e-05	0.000492	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	8.35e-05	0.000491	CcSEcCtD
Cyclosporine—Discomfort—Etoposide—uterine cancer	8.31e-05	0.000488	CcSEcCtD
Cyclosporine—Breast disorder—Epirubicin—uterine cancer	8.31e-05	0.000488	CcSEcCtD
Cyclosporine—Hypersensitivity—Dactinomycin—uterine cancer	8.2e-05	0.000482	CcSEcCtD
Cyclosporine—Gastritis—Epirubicin—uterine cancer	8.13e-05	0.000478	CcSEcCtD
Cyclosporine—Confusional state—Etoposide—uterine cancer	8.13e-05	0.000478	CcSEcCtD
Cyclosporine—Muscular weakness—Epirubicin—uterine cancer	8.11e-05	0.000476	CcSEcCtD
Cyclosporine—Anaphylactic shock—Etoposide—uterine cancer	8.06e-05	0.000474	CcSEcCtD
Cyclosporine—Mood swings—Doxorubicin—uterine cancer	8.06e-05	0.000474	CcSEcCtD
Cyclosporine—Infection—Etoposide—uterine cancer	8.01e-05	0.000471	CcSEcCtD
Cyclosporine—Abdominal distension—Epirubicin—uterine cancer	8e-05	0.00047	CcSEcCtD
Cyclosporine—Asthenia—Dactinomycin—uterine cancer	7.99e-05	0.00047	CcSEcCtD
Cyclosporine—Blood creatinine increased—Doxorubicin—uterine cancer	7.97e-05	0.000468	CcSEcCtD
Cyclosporine—Dysphagia—Epirubicin—uterine cancer	7.94e-05	0.000467	CcSEcCtD
Cyclosporine—Thrombocytopenia—Etoposide—uterine cancer	7.89e-05	0.000464	CcSEcCtD
Cyclosporine—Skin disorder—Etoposide—uterine cancer	7.83e-05	0.00046	CcSEcCtD
Cyclosporine—Dry skin—Doxorubicin—uterine cancer	7.8e-05	0.000458	CcSEcCtD
Cyclosporine—Hyperhidrosis—Etoposide—uterine cancer	7.79e-05	0.000458	CcSEcCtD
Cyclosporine—Pancreatitis—Epirubicin—uterine cancer	7.79e-05	0.000458	CcSEcCtD
Cyclosporine—Abdominal pain upper—Doxorubicin—uterine cancer	7.77e-05	0.000457	CcSEcCtD
Cyclosporine—Breast disorder—Doxorubicin—uterine cancer	7.69e-05	0.000452	CcSEcCtD
Cyclosporine—Anorexia—Etoposide—uterine cancer	7.68e-05	0.000452	CcSEcCtD
Cyclosporine—Bronchitis—Epirubicin—uterine cancer	7.64e-05	0.000449	CcSEcCtD
Cyclosporine—Diarrhoea—Dactinomycin—uterine cancer	7.62e-05	0.000448	CcSEcCtD
Cyclosporine—Gastritis—Doxorubicin—uterine cancer	7.53e-05	0.000442	CcSEcCtD
Cyclosporine—Muscular weakness—Doxorubicin—uterine cancer	7.5e-05	0.000441	CcSEcCtD
Cyclosporine—Dysuria—Epirubicin—uterine cancer	7.43e-05	0.000437	CcSEcCtD
Cyclosporine—Abdominal distension—Doxorubicin—uterine cancer	7.4e-05	0.000435	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Epirubicin—uterine cancer	7.38e-05	0.000434	CcSEcCtD
Cyclosporine—Dysphagia—Doxorubicin—uterine cancer	7.35e-05	0.000432	CcSEcCtD
Cyclosporine—Pollakiuria—Epirubicin—uterine cancer	7.34e-05	0.000431	CcSEcCtD
Cyclosporine—Paraesthesia—Etoposide—uterine cancer	7.24e-05	0.000425	CcSEcCtD
Cyclosporine—Weight increased—Epirubicin—uterine cancer	7.23e-05	0.000425	CcSEcCtD
Cyclosporine—Pancreatitis—Doxorubicin—uterine cancer	7.21e-05	0.000424	CcSEcCtD
Cyclosporine—Weight decreased—Epirubicin—uterine cancer	7.19e-05	0.000422	CcSEcCtD
Cyclosporine—Dyspnoea—Etoposide—uterine cancer	7.19e-05	0.000422	CcSEcCtD
Cyclosporine—Hyperglycaemia—Epirubicin—uterine cancer	7.17e-05	0.000421	CcSEcCtD
Cyclosporine—Somnolence—Etoposide—uterine cancer	7.16e-05	0.000421	CcSEcCtD
Cyclosporine—Pneumonia—Epirubicin—uterine cancer	7.12e-05	0.000419	CcSEcCtD
Cyclosporine—Infestation NOS—Epirubicin—uterine cancer	7.08e-05	0.000416	CcSEcCtD
Cyclosporine—Infestation—Epirubicin—uterine cancer	7.08e-05	0.000416	CcSEcCtD
Cyclosporine—Vomiting—Dactinomycin—uterine cancer	7.08e-05	0.000416	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—uterine cancer	7.07e-05	0.000415	CcSEcCtD
Cyclosporine—Rash—Dactinomycin—uterine cancer	7.02e-05	0.000413	CcSEcCtD
Cyclosporine—Decreased appetite—Etoposide—uterine cancer	7.01e-05	0.000412	CcSEcCtD
Cyclosporine—Renal failure—Epirubicin—uterine cancer	6.96e-05	0.000409	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Etoposide—uterine cancer	6.96e-05	0.000409	CcSEcCtD
Cyclosporine—Fatigue—Etoposide—uterine cancer	6.95e-05	0.000408	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Epirubicin—uterine cancer	6.94e-05	0.000408	CcSEcCtD
Cyclosporine—Jaundice—Epirubicin—uterine cancer	6.9e-05	0.000406	CcSEcCtD
Cyclosporine—Stomatitis—Epirubicin—uterine cancer	6.9e-05	0.000406	CcSEcCtD
Cyclosporine—Pain—Etoposide—uterine cancer	6.89e-05	0.000405	CcSEcCtD
Cyclosporine—Constipation—Etoposide—uterine cancer	6.89e-05	0.000405	CcSEcCtD
Cyclosporine—Urinary tract infection—Epirubicin—uterine cancer	6.89e-05	0.000405	CcSEcCtD
Cyclosporine—Conjunctivitis—Epirubicin—uterine cancer	6.89e-05	0.000405	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—uterine cancer	6.87e-05	0.000404	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—uterine cancer	6.83e-05	0.000402	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—uterine cancer	6.79e-05	0.000399	CcSEcCtD
Cyclosporine—Haematuria—Epirubicin—uterine cancer	6.75e-05	0.000397	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Epirubicin—uterine cancer	6.7e-05	0.000394	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—uterine cancer	6.69e-05	0.000393	CcSEcCtD
Cyclosporine—Epistaxis—Epirubicin—uterine cancer	6.68e-05	0.000393	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—uterine cancer	6.65e-05	0.000391	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—uterine cancer	6.65e-05	0.000391	CcSEcCtD
Cyclosporine—Feeling abnormal—Etoposide—uterine cancer	6.64e-05	0.00039	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—uterine cancer	6.63e-05	0.00039	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—uterine cancer	6.61e-05	0.000389	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—uterine cancer	6.59e-05	0.000387	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Etoposide—uterine cancer	6.59e-05	0.000387	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—uterine cancer	6.55e-05	0.000385	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—uterine cancer	6.55e-05	0.000385	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—uterine cancer	6.44e-05	0.000379	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—uterine cancer	6.42e-05	0.000378	CcSEcCtD
Cyclosporine—Urticaria—Etoposide—uterine cancer	6.4e-05	0.000376	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—uterine cancer	6.39e-05	0.000376	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—uterine cancer	6.39e-05	0.000375	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—uterine cancer	6.39e-05	0.000375	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—uterine cancer	6.37e-05	0.000375	CcSEcCtD
Cyclosporine—Abdominal pain—Etoposide—uterine cancer	6.37e-05	0.000374	CcSEcCtD
Cyclosporine—Body temperature increased—Etoposide—uterine cancer	6.37e-05	0.000374	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—uterine cancer	6.37e-05	0.000374	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—uterine cancer	6.37e-05	0.000374	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—uterine cancer	6.36e-05	0.000374	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—uterine cancer	6.36e-05	0.000374	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—uterine cancer	6.33e-05	0.000372	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—uterine cancer	6.31e-05	0.000371	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—uterine cancer	6.28e-05	0.000369	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—uterine cancer	6.25e-05	0.000367	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—uterine cancer	6.25e-05	0.000367	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—uterine cancer	6.23e-05	0.000366	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—uterine cancer	6.2e-05	0.000364	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—uterine cancer	6.18e-05	0.000363	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—uterine cancer	6.15e-05	0.000361	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—uterine cancer	6.13e-05	0.00036	CcSEcCtD
Cyclosporine—Hypersensitivity—Etoposide—uterine cancer	5.94e-05	0.000349	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—uterine cancer	5.93e-05	0.000348	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—uterine cancer	5.91e-05	0.000348	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—uterine cancer	5.9e-05	0.000347	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—uterine cancer	5.9e-05	0.000347	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—uterine cancer	5.88e-05	0.000346	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—uterine cancer	5.88e-05	0.000346	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—uterine cancer	5.85e-05	0.000344	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—uterine cancer	5.84e-05	0.000343	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—uterine cancer	5.81e-05	0.000341	CcSEcCtD
Cyclosporine—Asthenia—Etoposide—uterine cancer	5.78e-05	0.00034	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—uterine cancer	5.78e-05	0.00034	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—uterine cancer	5.77e-05	0.000339	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—uterine cancer	5.77e-05	0.000339	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—uterine cancer	5.73e-05	0.000337	CcSEcCtD
Cyclosporine—Chills—Epirubicin—uterine cancer	5.71e-05	0.000335	CcSEcCtD
Cyclosporine—Pruritus—Etoposide—uterine cancer	5.7e-05	0.000335	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—uterine cancer	5.68e-05	0.000334	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—uterine cancer	5.67e-05	0.000333	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—uterine cancer	5.62e-05	0.00033	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—uterine cancer	5.57e-05	0.000327	CcSEcCtD
Cyclosporine—ABCB1—lymph node—uterine cancer	5.56e-05	0.000548	CbGeAlD
Cyclosporine—Malnutrition—Epirubicin—uterine cancer	5.54e-05	0.000325	CcSEcCtD
Cyclosporine—Diarrhoea—Etoposide—uterine cancer	5.51e-05	0.000324	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—uterine cancer	5.49e-05	0.000322	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—uterine cancer	5.46e-05	0.000321	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—uterine cancer	5.45e-05	0.000321	CcSEcCtD
Cyclosporine—Tension—Epirubicin—uterine cancer	5.43e-05	0.000319	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—uterine cancer	5.42e-05	0.000319	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—uterine cancer	5.38e-05	0.000316	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—uterine cancer	5.34e-05	0.000314	CcSEcCtD
Cyclosporine—Dizziness—Etoposide—uterine cancer	5.33e-05	0.000313	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—uterine cancer	5.32e-05	0.000313	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—uterine cancer	5.3e-05	0.000312	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—uterine cancer	5.28e-05	0.00031	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—uterine cancer	5.26e-05	0.000309	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—uterine cancer	5.22e-05	0.000307	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—uterine cancer	5.2e-05	0.000306	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—uterine cancer	5.15e-05	0.000303	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—uterine cancer	5.14e-05	0.000302	CcSEcCtD
Cyclosporine—Vomiting—Etoposide—uterine cancer	5.12e-05	0.000301	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—uterine cancer	5.12e-05	0.000301	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—uterine cancer	5.12e-05	0.000301	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—uterine cancer	5.09e-05	0.000299	CcSEcCtD
Cyclosporine—Rash—Etoposide—uterine cancer	5.08e-05	0.000299	CcSEcCtD
Cyclosporine—Dermatitis—Etoposide—uterine cancer	5.08e-05	0.000298	CcSEcCtD
Cyclosporine—Headache—Etoposide—uterine cancer	5.05e-05	0.000297	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—uterine cancer	5.05e-05	0.000297	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—uterine cancer	5.03e-05	0.000295	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—uterine cancer	5.02e-05	0.000295	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—uterine cancer	4.99e-05	0.000293	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—uterine cancer	4.97e-05	0.000292	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—uterine cancer	4.97e-05	0.000292	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—uterine cancer	4.95e-05	0.000291	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—uterine cancer	4.92e-05	0.000289	CcSEcCtD
Cyclosporine—Cough—Epirubicin—uterine cancer	4.83e-05	0.000284	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—uterine cancer	4.83e-05	0.000284	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—uterine cancer	4.8e-05	0.000282	CcSEcCtD
Cyclosporine—Nausea—Etoposide—uterine cancer	4.79e-05	0.000281	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—uterine cancer	4.78e-05	0.000281	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—uterine cancer	4.75e-05	0.000279	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—uterine cancer	4.73e-05	0.000278	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—uterine cancer	4.71e-05	0.000277	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—uterine cancer	4.71e-05	0.000277	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—uterine cancer	4.71e-05	0.000277	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—uterine cancer	4.71e-05	0.000277	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—uterine cancer	4.7e-05	0.000276	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	4.68e-05	0.000275	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—uterine cancer	4.66e-05	0.000274	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—uterine cancer	4.62e-05	0.000271	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—uterine cancer	4.61e-05	0.000271	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—uterine cancer	4.6e-05	0.00027	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—uterine cancer	4.58e-05	0.000269	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—uterine cancer	4.56e-05	0.000268	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—uterine cancer	4.52e-05	0.000266	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—uterine cancer	4.52e-05	0.000266	CcSEcCtD
Cyclosporine—Infection—Epirubicin—uterine cancer	4.49e-05	0.000264	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—uterine cancer	4.47e-05	0.000263	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—uterine cancer	4.44e-05	0.000261	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—uterine cancer	4.43e-05	0.00026	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—uterine cancer	4.42e-05	0.00026	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—uterine cancer	4.42e-05	0.00026	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—uterine cancer	4.39e-05	0.000258	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—uterine cancer	4.37e-05	0.000257	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—uterine cancer	4.36e-05	0.000256	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—uterine cancer	4.36e-05	0.000256	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—uterine cancer	4.36e-05	0.000256	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—uterine cancer	4.35e-05	0.000255	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.33e-05	0.000255	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—uterine cancer	4.31e-05	0.000253	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—uterine cancer	4.31e-05	0.000253	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—uterine cancer	4.26e-05	0.000251	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—uterine cancer	4.21e-05	0.000248	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—uterine cancer	4.18e-05	0.000246	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—uterine cancer	4.18e-05	0.000246	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—uterine cancer	4.15e-05	0.000244	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.12e-05	0.000242	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—uterine cancer	4.1e-05	0.000241	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—uterine cancer	4.09e-05	0.000241	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—uterine cancer	4.09e-05	0.00024	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—uterine cancer	4.06e-05	0.000239	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—uterine cancer	4.06e-05	0.000238	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—uterine cancer	4.04e-05	0.000238	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—uterine cancer	4.03e-05	0.000237	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—uterine cancer	4.02e-05	0.000236	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—uterine cancer	3.98e-05	0.000234	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—uterine cancer	3.98e-05	0.000234	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—uterine cancer	3.93e-05	0.000231	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—uterine cancer	3.9e-05	0.000229	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—uterine cancer	3.89e-05	0.000229	CcSEcCtD
Cyclosporine—Pain—Epirubicin—uterine cancer	3.86e-05	0.000227	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—uterine cancer	3.86e-05	0.000227	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.81e-05	0.000224	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—uterine cancer	3.78e-05	0.000222	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—uterine cancer	3.75e-05	0.000221	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—uterine cancer	3.73e-05	0.000219	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—uterine cancer	3.72e-05	0.000219	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—uterine cancer	3.72e-05	0.000218	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—uterine cancer	3.69e-05	0.000217	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—uterine cancer	3.68e-05	0.000216	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—uterine cancer	3.63e-05	0.000214	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—uterine cancer	3.61e-05	0.000212	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—uterine cancer	3.6e-05	0.000212	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—uterine cancer	3.59e-05	0.000211	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—uterine cancer	3.57e-05	0.00021	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—uterine cancer	3.57e-05	0.00021	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—uterine cancer	3.57e-05	0.00021	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—uterine cancer	3.57e-05	0.00021	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—uterine cancer	3.44e-05	0.000202	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—uterine cancer	3.42e-05	0.000201	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—uterine cancer	3.33e-05	0.000196	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—uterine cancer	3.32e-05	0.000195	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—uterine cancer	3.3e-05	0.000194	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—uterine cancer	3.3e-05	0.000194	CcSEcCtD
Cyclosporine—Asthenia—Epirubicin—uterine cancer	3.24e-05	0.000191	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—uterine cancer	3.2e-05	0.000188	CcSEcCtD
Cyclosporine—Diarrhoea—Epirubicin—uterine cancer	3.09e-05	0.000182	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—uterine cancer	3.08e-05	0.000181	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—uterine cancer	3e-05	0.000176	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—uterine cancer	2.99e-05	0.000176	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—uterine cancer	2.96e-05	0.000174	CcSEcCtD
Cyclosporine—Vomiting—Epirubicin—uterine cancer	2.87e-05	0.000169	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—uterine cancer	2.86e-05	0.000168	CcSEcCtD
Cyclosporine—Rash—Epirubicin—uterine cancer	2.85e-05	0.000167	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—uterine cancer	2.85e-05	0.000167	CcSEcCtD
Cyclosporine—Headache—Epirubicin—uterine cancer	2.83e-05	0.000166	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—uterine cancer	2.76e-05	0.000162	CcSEcCtD
Cyclosporine—Nausea—Epirubicin—uterine cancer	2.68e-05	0.000158	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—uterine cancer	2.66e-05	0.000156	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—uterine cancer	2.64e-05	0.000155	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—uterine cancer	2.63e-05	0.000155	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—uterine cancer	2.62e-05	0.000154	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—uterine cancer	2.48e-05	0.000146	CcSEcCtD
Cyclosporine—CYP3A5—Metabolism—POLD1—uterine cancer	1.17e-05	0.000135	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.17e-05	0.000135	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—STK11—uterine cancer	1.16e-05	0.000134	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.000134	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.15e-05	0.000133	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—STAR—uterine cancer	1.15e-05	0.000133	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ESR1—uterine cancer	1.14e-05	0.000132	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.14e-05	0.000132	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.14e-05	0.000132	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—STAR—uterine cancer	1.13e-05	0.00013	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.13e-05	0.00013	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PIK3CA—uterine cancer	1.12e-05	0.000129	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN2B—uterine cancer	1.12e-05	0.000129	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.11e-05	0.000129	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CDKN1B—uterine cancer	1.11e-05	0.000128	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—PIK3CA—uterine cancer	1.1e-05	0.000127	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KRAS—uterine cancer	1.1e-05	0.000126	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.1e-05	0.000126	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.09e-05	0.000125	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—ERBB2—uterine cancer	1.08e-05	0.000125	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—PIK3CA—uterine cancer	1.08e-05	0.000124	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.06e-05	0.000123	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—STAR—uterine cancer	1.06e-05	0.000122	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.06e-05	0.000122	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—STAR—uterine cancer	1.05e-05	0.000121	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.05e-05	0.000121	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CTNNB1—uterine cancer	1.05e-05	0.000121	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—MTHFR—uterine cancer	1.04e-05	0.00012	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CYP19A1—uterine cancer	1.04e-05	0.00012	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—STK11—uterine cancer	1.04e-05	0.00012	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.04e-05	0.00012	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.04e-05	0.00012	CbGpPWpGaD
Cyclosporine—PPIA—Disease—HRAS—uterine cancer	1.04e-05	0.000119	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CXCL8—uterine cancer	1.03e-05	0.000118	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PTEN—uterine cancer	1.02e-05	0.000118	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—HRAS—uterine cancer	1.02e-05	0.000118	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SMAD3—uterine cancer	1.02e-05	0.000117	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—POLD1—uterine cancer	1.01e-05	0.000117	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—KRAS—uterine cancer	1.01e-05	0.000117	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—PIK3CA—uterine cancer	1.01e-05	0.000116	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL2—uterine cancer	1.01e-05	0.000116	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.01e-05	0.000116	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CDKN1B—uterine cancer	1e-05	0.000116	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—MTHFR—uterine cancer	1e-05	0.000115	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CYP19A1—uterine cancer	9.91e-06	0.000114	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—STK11—uterine cancer	9.91e-06	0.000114	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PTEN—uterine cancer	9.84e-06	0.000113	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.79e-06	0.000113	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—RRM2—uterine cancer	9.77e-06	0.000113	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EP300—uterine cancer	9.75e-06	0.000112	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FGFR2—uterine cancer	9.72e-06	0.000112	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NDUFB11—uterine cancer	9.6e-06	0.000111	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SRD5A2—uterine cancer	9.6e-06	0.000111	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKR1C1—uterine cancer	9.49e-06	0.000109	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—DCN—uterine cancer	9.48e-06	0.000109	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CTNNB1—uterine cancer	9.47e-06	0.000109	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—EP300—uterine cancer	9.39e-06	0.000108	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MTHFR—uterine cancer	9.35e-06	0.000108	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.33e-06	0.000108	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HRAS—uterine cancer	9.32e-06	0.000107	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PIK3CA—uterine cancer	9.3e-06	0.000107	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.3e-06	0.000107	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PTEN—uterine cancer	9.23e-06	0.000106	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.19e-06	0.000106	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—STK11—uterine cancer	9.17e-06	0.000106	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CYP19A1—uterine cancer	9.17e-06	0.000106	CbGpPWpGaD
Cyclosporine—PPIA—Disease—AKT1—uterine cancer	9.15e-06	0.000105	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—NRAS—uterine cancer	9.12e-06	0.000105	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CYP19A1—uterine cancer	9.09e-06	0.000105	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—STK11—uterine cancer	9.09e-06	0.000105	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—POLD1—uterine cancer	9.06e-06	0.000104	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—AKT1—uterine cancer	9.01e-06	0.000104	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP11A1—uterine cancer	8.93e-06	0.000103	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.87e-06	0.000102	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—POLD1—uterine cancer	8.84e-06	0.000102	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.81e-06	0.000102	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EP300—uterine cancer	8.81e-06	0.000102	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—AKT1—uterine cancer	8.8e-06	0.000101	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—MTHFR—uterine cancer	8.71e-06	0.0001	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—HRAS—uterine cancer	8.61e-06	9.92e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	8.56e-06	9.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKR1C1—uterine cancer	8.47e-06	9.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—RRM2—uterine cancer	8.46e-06	9.75e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKR1C3—uterine cancer	8.44e-06	9.72e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ERBB2—uterine cancer	8.4e-06	9.68e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—VEGFA—uterine cancer	8.34e-06	9.61e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—POLD1—uterine cancer	8.33e-06	9.6e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKR1C1—uterine cancer	8.27e-06	9.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—POLD1—uterine cancer	8.26e-06	9.52e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NRAS—uterine cancer	8.24e-06	9.5e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—AKT1—uterine cancer	8.23e-06	9.49e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—DCN—uterine cancer	8.21e-06	9.47e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL8—uterine cancer	7.96e-06	9.18e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.87e-06	9.07e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—uterine cancer	7.85e-06	9.05e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—MTHFR—uterine cancer	7.83e-06	9.03e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKR1C1—uterine cancer	7.79e-06	8.98e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CDKN1B—uterine cancer	7.78e-06	8.96e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP11A1—uterine cancer	7.74e-06	8.92e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKR1C1—uterine cancer	7.73e-06	8.9e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.67e-06	8.84e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.61e-06	8.77e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—AKT1—uterine cancer	7.6e-06	8.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—RRM2—uterine cancer	7.55e-06	8.7e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—MTHFR—uterine cancer	7.45e-06	8.58e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—RRM2—uterine cancer	7.37e-06	8.5e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CTNNB1—uterine cancer	7.35e-06	8.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—DCN—uterine cancer	7.33e-06	8.45e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKR1C3—uterine cancer	7.31e-06	8.42e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PIK3CA—uterine cancer	7.21e-06	8.31e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTEN—uterine cancer	7.16e-06	8.25e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—DCN—uterine cancer	7.16e-06	8.25e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—uterine cancer	7.09e-06	8.17e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—RRM2—uterine cancer	6.95e-06	8.01e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—uterine cancer	6.94e-06	8e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—STAR—uterine cancer	6.94e-06	8e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.94e-06	8e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP11A1—uterine cancer	6.91e-06	7.96e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.9e-06	7.96e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—MTHFR—uterine cancer	6.89e-06	7.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—RRM2—uterine cancer	6.89e-06	7.94e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—MTHFR—uterine cancer	6.83e-06	7.88e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EP300—uterine cancer	6.83e-06	7.87e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—DCN—uterine cancer	6.74e-06	7.77e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP11A1—uterine cancer	6.74e-06	7.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—DCN—uterine cancer	6.68e-06	7.7e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—uterine cancer	6.67e-06	7.69e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—STK11—uterine cancer	6.57e-06	7.58e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP19A1—uterine cancer	6.57e-06	7.58e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.56e-06	7.56e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKR1C3—uterine cancer	6.52e-06	7.52e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—uterine cancer	6.51e-06	7.51e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—uterine cancer	6.47e-06	7.45e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.43e-06	7.41e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—uterine cancer	6.39e-06	7.36e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKR1C3—uterine cancer	6.37e-06	7.34e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP11A1—uterine cancer	6.35e-06	7.32e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—uterine cancer	6.3e-06	7.26e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP11A1—uterine cancer	6.3e-06	7.26e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—uterine cancer	6.1e-06	7.03e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—uterine cancer	6.03e-06	6.95e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKR1C3—uterine cancer	6e-06	6.91e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKR1C3—uterine cancer	5.95e-06	6.85e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—uterine cancer	5.89e-06	6.79e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—uterine cancer	5.8e-06	6.69e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP19A1—uterine cancer	5.69e-06	6.56e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—STK11—uterine cancer	5.69e-06	6.56e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—uterine cancer	5.67e-06	6.54e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1B—uterine cancer	5.65e-06	6.51e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—uterine cancer	5.56e-06	6.41e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—EP300—uterine cancer	5.53e-06	6.38e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—uterine cancer	5.5e-06	6.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—POLD1—uterine cancer	5.45e-06	6.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.34e-06	6.16e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—uterine cancer	5.34e-06	6.15e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—uterine cancer	5.32e-06	6.13e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—EP300—uterine cancer	5.3e-06	6.11e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—uterine cancer	5.2e-06	6e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.1e-06	5.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.1e-06	5.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—STK11—uterine cancer	5.08e-06	5.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.08e-06	5.86e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—uterine cancer	5.05e-06	5.82e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EP300—uterine cancer	4.96e-06	5.72e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—STK11—uterine cancer	4.96e-06	5.72e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP19A1—uterine cancer	4.96e-06	5.72e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—MTHFR—uterine cancer	4.94e-06	5.69e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—uterine cancer	4.89e-06	5.63e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—uterine cancer	4.84e-06	5.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.77e-06	5.5e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—STK11—uterine cancer	4.67e-06	5.39e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP19A1—uterine cancer	4.67e-06	5.39e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—uterine cancer	4.67e-06	5.39e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—uterine cancer	4.64e-06	5.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—STK11—uterine cancer	4.63e-06	5.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP19A1—uterine cancer	4.63e-06	5.34e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—EP300—uterine cancer	4.62e-06	5.32e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.55e-06	5.24e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—RRM2—uterine cancer	4.54e-06	5.23e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—DCN—uterine cancer	4.41e-06	5.08e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—uterine cancer	4.36e-06	5.02e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.35e-06	5.01e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—MTHFR—uterine cancer	4.28e-06	4.93e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—EP300—uterine cancer	4.16e-06	4.79e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.15e-06	4.79e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.15e-06	4.78e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—uterine cancer	4.14e-06	4.77e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—uterine cancer	4.13e-06	4.76e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—uterine cancer	4.09e-06	4.72e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—uterine cancer	4e-06	4.61e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—EP300—uterine cancer	3.95e-06	4.55e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—uterine cancer	3.92e-06	4.52e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.92e-06	4.52e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—uterine cancer	3.84e-06	4.42e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—MTHFR—uterine cancer	3.82e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—uterine cancer	3.8e-06	4.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.77e-06	4.35e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—MTHFR—uterine cancer	3.73e-06	4.3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—uterine cancer	3.67e-06	4.23e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—EP300—uterine cancer	3.66e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—EP300—uterine cancer	3.63e-06	4.18e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—MTHFR—uterine cancer	3.51e-06	4.05e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—MTHFR—uterine cancer	3.48e-06	4.01e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—uterine cancer	3.42e-06	3.94e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—uterine cancer	3.4e-06	3.91e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.37e-06	3.88e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—uterine cancer	3.34e-06	3.85e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—uterine cancer	3.21e-06	3.69e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—uterine cancer	3.07e-06	3.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.07e-06	3.54e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—STK11—uterine cancer	3.06e-06	3.52e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.06e-06	3.52e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—uterine cancer	3e-06	3.46e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—uterine cancer	2.92e-06	3.37e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—uterine cancer	2.79e-06	3.22e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—uterine cancer	2.75e-06	3.17e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—uterine cancer	2.71e-06	3.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—uterine cancer	2.68e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—EP300—uterine cancer	2.62e-06	3.02e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—uterine cancer	2.51e-06	2.89e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—uterine cancer	2.39e-06	2.75e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—uterine cancer	2.38e-06	2.74e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.3e-06	2.65e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—EP300—uterine cancer	2.27e-06	2.62e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—uterine cancer	2.21e-06	2.55e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—uterine cancer	2.19e-06	2.52e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—uterine cancer	2.12e-06	2.45e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—uterine cancer	2.07e-06	2.39e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—EP300—uterine cancer	2.03e-06	2.33e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—EP300—uterine cancer	1.98e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—uterine cancer	1.95e-06	2.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.94e-06	2.23e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—uterine cancer	1.94e-06	2.23e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—EP300—uterine cancer	1.86e-06	2.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—EP300—uterine cancer	1.85e-06	2.13e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.68e-06	1.94e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—uterine cancer	1.58e-06	1.83e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.5e-06	1.73e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—uterine cancer	1.46e-06	1.69e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.38e-06	1.59e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—uterine cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.37e-06	1.57e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—uterine cancer	1.28e-06	1.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—uterine cancer	1.22e-06	1.41e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—EP300—uterine cancer	1.22e-06	1.4e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—uterine cancer	1.19e-06	1.38e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—uterine cancer	1.13e-06	1.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—uterine cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—uterine cancer	9.01e-07	1.04e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—uterine cancer	7.36e-07	8.49e-06	CbGpPWpGaD
